Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypox

Nature Medicine

Volumn 11, Issue 9, 2005, Pages 1005-1011

  Hammarlund, Erika ^a   Lewis, Matthew W ^a   Carter, Shirley V ^a   Amanna, Ian ^a   Hansen, Scott G ^a   Strelow, Lisa I ^a   Wong, Scott W ^a   Yoshihara, Paul ^a   Hanifin, Jon M ^a   Slifka, Mark K ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONKEYPOX VACCINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; EPIDEMIC; HUMAN; HUMAN CELL; MONKEYPOX; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SYMPTOM; UNITED STATES; VACCINATION; VALIDATION PROCESS; VIRUS IMMUNITY;

ANIMALS; ANTIBODIES, VIRAL; CROSS REACTIONS; DISEASE OUTBREAKS; DISEASE RESERVOIRS; HUMANS; MONKEYPOX; SCIURIDAE; SMALLPOX VACCINE; T-LYMPHOCYTES; TIME FACTORS; WISCONSIN; ZOONOSES;

ORTHOPOXVIRUS; VARIOLA VIRUS;

EID: 24744462674     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1273     Document Type: Article

References (30)

1. Henderson, D.A. The looming threat of bioterrorism. Science 283, 1279-1282 (1999).
2. Jezek, Z. et al. Human monkeypox: a study of 2,510 contacts of 214 patients. J. Infect. Dis. 154, 551-555 (1986).
3. Jezek, Z., Szczeniowski, M., Paluku, K.M. & Mutombo, M. Human monkeypox: clinical features of 282 patients. J. Infect. Dis. 156, 293-298 (1987).
4. Jezek, Z., Grab, B., Paluku, K.M. & Szczeniowski, M.V. Human monkeypox: disease pattern, incidence and attack rates in a rural area of northern Zaire. Trop. Geogr. Med. 40, 73-83 (1988).
5. Hutin, Y.J. et al. Outbreak of human monkeypox, Democratic Republic of Congo, 1996 to 1997. Emerg. Infect. Dis. 7, 434-438 (2001).
6. Meyer, H. et al. Outbreaks of disease suspected of being due to human monkeypox virus infection in the democratic republic of congo in 2001. J. Clin. Microbiol. 40, 2919-2921 (2002).
7. Smith, G.L. & McFadden, G. Smallpox: anything to declare? Nat. Rev. Immunol. 2, 521-527 (2002).
8. Centers for Disease Control and Prevention. Update: multistate outbreak of monkeypox - Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003. MMWR Morb. Mortal. Wkly. Rep. 52, 642-646 (2003).
9. Gross, E. Update on emerging infections: news from the Centers for Disease Control and prevention. Update: Multistate outbreak of monkeypox-lllinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003. Ann. Emerg. Med. 42, 660-662 discussion; 662-664 (2003).
10. Seward, J.F. et al. Development and experience with an algorithm to evaluate suspected smallpox cases in the United States, 2002-2004. Clin. Infect. Dis. 39, 1477-1483 (2004).
11. Reed, K.D. et al. The detection of monkeypox in humans in the Western Hemisphere. N. Engl. J. Med. 350, 342-350 (2004).
12. Klein, K.R., Atas, J.G. & Collins, J. Testing emergency medical personnel response to patients with suspected infectious disease. Prehospital Disaster Med. 19, 256-265 (2004).
13. Di Giulio, D.B. & Eckburg, P.B. Human monkeypox: an emerging zoonosis. Lancet Infect. Dis. 4, 15-25 (2004).
14. Hammarlund, E. et al. Duration of antiviral immunity after smallpox vaccination. Nat. Med. 9, 1131-1137 (2003).
15. Esposito, J.J., Obijeski, J.F. & Nakano, J.H. Serological relatedness of monkeypox, variola, and vaccinia viruses. J. Med. Virol. 1, 35-47 (1977).
16. Hutchinson, H.D., Ziegler, D.W., Wells, D.E. & Nakano, J.H. Differentiation of variola, monkeypox, and vaccinia antisera by radioimmunoassay. Bull. World Health Organ. 55, 613-623 (1977).
17. Jezek, Z. et al. Serological survey for human monkeypox infections in a selected population in Zaire. J. Trop. Med. Hyg. 90, 31-38 (1987).
18. Slifka, M.K. Immunological memory to viral infection. Curr. Opin. Immunol. 16, 443-450 (2004).
19. Amara, R.R., Nigam, P., Sharma, S., Liu, J. & Bostik, V. Long-lived poxvirus immunity, robust CD4 help, and better persistence of CD4 than CD8 T cells. J. Virol. 78, 3811-3816 (2004).
20. Shchelkunov, S.N. et al. Analysis of the monkeypox virus genome. Virology 297, 172-194 (2002).
21. Sofi Ibrahim, M. et al. Real-time PCR assay to detect smallpox virus. J. Clin. Microbiol. 41, 3835-3839 (2003).
22. Baxby, D., Bennett, M. & Getty, B. Human cowpox 1969-93: a review based on 54 cases. Br. J. Dermatol. 131, 598-607 (1994).
23. Hawranek, T. et al. Feline orthopoxvirus infection transmitted from cat to human. J. Am. Acad. Dermatol. 49, 513-518 (2003).
24. Pelkonen, P.M. et al. Cowpox with severe generalized eruption, Finland. Emerg. Infect. Dis. 9, 1458-1461 (2003).
25. Mack, T.M., Noble, J. Jr. & Thomas, D.B. A prospective study of serum antibody and protection against smallpox. Am. J. Trop. Med. Hyg. 21, 214-218 (1972).
26. Sarkar, J.K., Mitra, A.C. & Mukherjee, M.K. The minimum protective level of antibodies in smallpox. Bull. World Health Organ. 52, 307-311 (1975).
27. Heiner, G.G. et al. A study of inapparent infection in smallpox. Am. J. Epidemiol. 94, 252-268 (1971).
28. Update: multistate outbreak of monkeypox - Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003. MMWR Morb. Mortal. Wkly. Rep. 52, 561-564 (2003).
29. CDC. Multistate outbreak of monkeypox - Illinois, Indiana, and Wisconsin, 2003. MMWR Morb. Mortal. Wkly. Rep. 52, 537-540 (2003).
30. Anderson, M.G., Frenkel, L.D., Homann, S. & Guffey, J. A case of severe monkeypox virus disease in an American child: emerging infections and changing professional values. Pediatr. Infect. Dis. J 22, 1093-1096 discussion; 1096-1098 (2003).